99 related articles for article (PubMed ID: 17634425)
21. Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2.
Kool J; Hamdi M; Cornelissen-Steijger P; van der Eb AJ; Terleth C; van Dam H
Oncogene; 2003 Jul; 22(27):4235-42. PubMed ID: 12833146
[TBL] [Abstract][Full Text] [Related]
22. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
Lindström MS; Wiman KG
Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
[TBL] [Abstract][Full Text] [Related]
23. DNA-dependent protein kinase enhances DNA damage-induced apoptosis in association with Friend gp70.
Yamaguchi S; Hasegawa M; Aizawa S; Tanaka K; Yoshida K; Noda Y; Tatsumi K; Hirokawa K; Kitagawa M
Leuk Res; 2005 Mar; 29(3):307-16. PubMed ID: 15661267
[TBL] [Abstract][Full Text] [Related]
24. Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.
Hong S; Pusapati RV; Powers JT; Johnson DG
Cell Cycle; 2006 Apr; 5(8):801-3. PubMed ID: 16582589
[TBL] [Abstract][Full Text] [Related]
25. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.
Pusapati RV; Rounbehler RJ; Hong S; Powers JT; Yan M; Kiguchi K; McArthur MJ; Wong PK; Johnson DG
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1446-51. PubMed ID: 16432227
[TBL] [Abstract][Full Text] [Related]
26. ATM controls c-Myc and DNA synthesis during postnatal thymocyte development through regulation of redox state.
Yan M; Zhu C; Liu N; Jiang Y; Scofield VL; Riggs PK; Qiang W; Lynn WS; Wong PK
Free Radic Biol Med; 2006 Aug; 41(4):640-8. PubMed ID: 16863997
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species abrogate the anticarcinogenic effect of eicosapentaenoic acid in Atm-deficient mice.
Schubert R; Reichenbach J; Koch C; Kloess S; Koehl U; Mueller K; Baer P; Beermann C; Boehles H; Zielen S
Nutr Cancer; 2010; 62(5):584-92. PubMed ID: 20574919
[TBL] [Abstract][Full Text] [Related]
28. Tumor suppression by p53 in the absence of Atm.
Bailey SL; Gurley KE; Hoon-Kim K; Kelly-Spratt KS; Kemp CJ
Mol Cancer Res; 2008 Jul; 6(7):1185-92. PubMed ID: 18583527
[TBL] [Abstract][Full Text] [Related]
29. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
30. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
Li J; Sejas DP; Burma S; Chen DJ; Pang Q
Carcinogenesis; 2007 Jun; 28(6):1163-70. PubMed ID: 17277230
[TBL] [Abstract][Full Text] [Related]
31. EBV latent membrane protein 2A orchestrates p27
Fish K; Sora RP; Schaller SJ; Longnecker R; Ikeda M
Blood; 2017 Dec; 130(23):2516-2526. PubMed ID: 29074502
[TBL] [Abstract][Full Text] [Related]
32. Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis.
Carr MI; Roderick JE; Gannon HS; Kelliher MA; Jones SN
Cell Rep; 2016 Sep; 16(10):2618-2629. PubMed ID: 27568562
[TBL] [Abstract][Full Text] [Related]
33. Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition.
Höglund A; Strömvall K; Li Y; Forshell LP; Nilsson JA
Cell Cycle; 2011 Oct; 10(20):3598-607. PubMed ID: 22030621
[TBL] [Abstract][Full Text] [Related]
34. Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs.
Happo L; Phipson B; Smyth GK; Strasser A; Scott CL
Cell Death Dis; 2012 May; 3(5):e306. PubMed ID: 22573037
[TBL] [Abstract][Full Text] [Related]
35. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis.
Opavsky R; Tsai SY; Guimond M; Arora A; Opavska J; Becknell B; Kaufmann M; Walton NA; Stephens JA; Fernandez SA; Muthusamy N; Felsher DW; Porcu P; Caligiuri MA; Leone G
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15400-5. PubMed ID: 17881568
[TBL] [Abstract][Full Text] [Related]
36. ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis.
Vaites LP; Lian Z; Lee EK; Yin B; DeMicco A; Bassing CH; Diehl JA
Oncogene; 2014 Jan; 33(1):129-33. PubMed ID: 23318439
[TBL] [Abstract][Full Text] [Related]
37. Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.
Gramling MW; Eischen CM
Cell Death Differ; 2012 Jul; 19(7):1220-7. PubMed ID: 22301919
[TBL] [Abstract][Full Text] [Related]
38. Cdk2 suppresses cellular senescence induced by the c-myc oncogene.
Campaner S; Doni M; Hydbring P; Verrecchia A; Bianchi L; Sardella D; Schleker T; Perna D; Tronnersjö S; Murga M; Fernandez-Capetillo O; Barbacid M; Larsson LG; Amati B
Nat Cell Biol; 2010 Jan; 12(1):54-9; sup pp 1-14. PubMed ID: 20010815
[TBL] [Abstract][Full Text] [Related]
39. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation.
Scott CL; Schuler M; Marsden VS; Egle A; Pellegrini M; Nesic D; Gerondakis S; Nutt SL; Green DR; Strasser A
J Cell Biol; 2004 Jan; 164(1):89-96. PubMed ID: 14709542
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.
Sipos F; Firneisz G; Műzes G
World J Gastroenterol; 2016 Sep; 22(35):7938-50. PubMed ID: 27672289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
